ChromaDex to begin the first human trials
date:Apr 22, 2013
ChromaDex, a natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food beverage, animal health, cosmetic and pharmaceutical industries, has announced the initiation of the first human clinical study in the U.S. for PURENERGY.

PURENERGY is a patented co-crystal ingredient comprised of caffeine and ChromaDex's pTeroPure pterostilbene that forms a unique crystalline structure that is said to have superior benefits compared to the t
1/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/30 17:35